Efalizumab: a review of events reported during clinical trials and side effects
Author:
Affiliation:
1. Chief of Dermatology Consultation Service, St Lukes Roosevelt Hospital, Department of Dermatology, 1090 Amsterdam Avenue, New York, NY 10025, USA.
Publisher
Informa Healthcare
Subject
Pharmacology (medical),General Medicine
Link
https://www.tandfonline.com/doi/pdf/10.1517/14740338.5.2.197
Reference18 articles.
1. NO AUTHORS LISTED: RAPTIVA® (efalizumab) package insert. South San Francisco, CA: Genentech, Inc. (2005).
2. A Novel Targeted T-Cell Modulator, Efalizumab, for Plaque Psoriasis
3. Efficacy and Safety Observed During 24 Weeks of Efalizumab Therapy in Patients With Moderate to Severe Plaque Psoriasis
4. Efalizumab for Patients With Moderate to Severe Plaque Psoriasis
Cited by 84 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Integrative Approaches for the Diagnosis and Management of Erosive Oral Lichen Planus;Diagnostics;2024-03-26
2. Esculin alleviates LPS-induced acute lung injury via inhibiting neutrophil recruitment and migration;International Immunopharmacology;2023-06
3. β2-integrins in Immunity: New Roles for Old Players;Integrins in Health and Disease;2023
4. Effects of β2 Integrins on Osteoclasts, Macrophages, Chondrocytes, and Synovial Fibroblasts in Osteoarthritis;Biomolecules;2022-11-08
5. α4-Integrin (and Other Leukocyte Integrin)-Targeting Agents;Infectious Complications in Biologic and Targeted Therapies;2022
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3